BioSpace News Archive

MFG Chemical received an Award for Safety Performance Improvement from SOCMA (Society of Chemical Manufacturers & Affiliates), at the trade association’s 96th Annual Dinner, held December 10 at the Crowne Plaza in NYC.

BT-11 was safe and well-tolerated at all doses evaluated and supports initiation of Phase 2 program in IBD patients in 1st half of 2019

In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.

ExThera, an early-stage device company in the Bay Area, is a developer of device-based therapies for removing bacteria and viruses from blood.

First Adimab Antibody to Enter the Market

Announces closing of 51% acquisition of regenerative medicine company Regentys™

Specific financial terms of the agreement have not been disclosed.

CytoSorbents achieved another year of record growth with total revenue of more than $22.3 million, including product sales of approximately $20.2 million, a 51% increase from a year ago [07-January-2019] MONMOUTH JUNCTION, N.J. , Jan. 7, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb

Jung joins from Molina Healthcare with more than 20 years of experience

The global orthopedic biomaterials market research report by Technavio predicts the market to post a CAGR of approximately 7% during the period 2018-2022.